Hematopoietic stem cell transplantation and hematopoietic stem cell gene therapy in X-linked adrenoleukodystrophy.

Brain Pathology
Nathalie Cartier, Patrick Aubourg

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) is the only therapeutic approach that can arrest cerebral demyelination of X-linked adrenoleukodystrophy (ALD) in boys and results in long-term in a good quality of life, provided the procedure is performed at an early stage of disease. Similar benefits of allogeneic HSCT have been demonstrated in adults with cerebral ALD. However, it is not yet known whether allogeneic HSCT can prevent or rescue adrenomyeloneuropathy. Allogeneic HSCT remains associated with significant morbidity and mortality risks, particularly in adults, and not all ALD patients have donors despite the availability of cord blood. The absence of biological markers that can predict the evolutivity of cerebral disease is a major limitation to propose in due time allogeneic HSCT to ALD patients. Recently, HSC gene therapy using lentiviral vector was shown to have comparable efficacy than allogeneic HSCT in two boys with cerebral ALD who had no Human-leukocyte-antigen (HLA)-matched donor. If these results are confirmed in an extended series of patients, HSC gene therapy may become the first therapeutic option for all ALD male patients who develop cerebral demyelination.

References

Jan 1, 1992·Neuroscience·L J LawsonS Gordon
Jan 1, 1991·International Review of Cytology·V H Perry, S Gordon
Nov 1, 1984·Neurology·H W MoserC L White
Jan 1, 1995·Journal of Inherited Metabolic Disease·E G ShapiroW Krivit
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·M A Eglitis, E Mezey
May 1, 1997·Acta Paediatrica·G MalmC Marcus
Nov 5, 1997·The Journal of Pediatrics·M J NowaczykJ T Clarke
Jun 17, 1998·Journal of Pediatric Hematology/oncology·J KapelushnikA Nagler
Apr 28, 2000·Science·M Cavazzana-CalvoA Fischer
Dec 18, 2002·European Journal of Pediatrics·Matthias BaumannFolker Hanefeld
Apr 2, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sonia BenhamidaNathalie Cartier
Mar 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Muriel AsheuerNathalie Cartier
Sep 30, 2005·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·T HitomiH Shibasaki
Apr 20, 2006·Arquivos de neuro-psiquiatria·Marcos C LangeCarmen M S Bonfim
Feb 10, 2007·Bone Marrow Transplantation·J TolarL Charnas
Mar 27, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·William Ying Khee HwangYeh Ching Linn
May 29, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Donald BeamMaria L Escolar
Nov 21, 2007·Nature Neuroscience·Bahareh AjamiFabio M V Rossi
Apr 9, 2008·Trends in Immunology·Nathalie DavoustSerge Nataf
Jun 24, 2008·Annals of Neurology·Florian S EichlerRichard M Ransohoff
Aug 9, 2008·The Journal of Clinical Investigation·Salima Hacein-Bey-AbinaMarina Cavazzana-Calvo
Oct 14, 2008·Bone Marrow Transplantation·M Y ShapiraR Or
Jun 18, 2009·Brain : a Journal of Neurology·Alexander MildnerMarco Prinz

❮ Previous
Next ❯

Citations

Sep 2, 1998·The Annals of Thoracic Surgery·A JeppssonC G McGregor
Apr 9, 2002·Fertility and Sterility·John M StribleyGregory M Christman
Nov 11, 2011·European Journal of Human Genetics : EJHG·Ernst KrasemannAndreas Gal
Nov 19, 2011·Human Molecular Genetics·Agatha SchlüterAurora Pujol
Oct 14, 2011·Viruses·Ali NowrouziManfred Schmidt
Dec 5, 2012·Advanced Biomedical Research·Nouri NayerossadatPalizban Abas Ali
Aug 12, 2014·Acta Neuropathologica·Nathalie CartierFabio M V Rossi
May 10, 2011·Expert Opinion on Biological Therapy·Angela Gritti
Dec 9, 2015·Annual Review of Biomedical Engineering·Melissa A KottermanDavid V Schaffer
Jun 27, 2014·Transplant Infectious Disease : an Official Journal of the Transplantation Society·K W KangI Kim
Jul 19, 2013·Case Reports in Neurological Medicine·Gyda Hlin Skuladottir JackMarianne Andersen
Mar 31, 2015·Cell Death and Differentiation·L MoratóA Pujol
Jun 30, 2012·Biochemical and Biophysical Research Communications·Yuanli LiFeng Liu
Mar 6, 2015·Radiologia brasileira·Sergio Eiji OnoLisandro Lima Ribeiro
Feb 23, 2011·Arquivos brasileiros de endocrinologia e metabologia·Fernanda Caroline SoardiMaricilda Palandi de Mello
Mar 10, 2017·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Christel TranSaadet Mercimek-Mahmutoglu
Feb 26, 2016·Neuropharmacology·Sourav R ChoudhuryPaola Grandi
Sep 26, 2012·Cell Transplantation·Catarina Oliveira MirandaCarla Andreia Teixeira
Apr 28, 2012·AJNR. American Journal of Neuroradiology·A MartinC Adamsbaum
Apr 5, 2013·Stem Cells·Jeanne GrosselinPhilippe Leboulch
Dec 30, 2017·Human Gene Therapy·Qiong LinDe-Pei Liu
Oct 17, 2017·Human Gene Therapy·Françoise PiguetNathalie Cartier
Jul 16, 2010·Brain Pathology·Isidro FerrerAurora Pujol
Jul 16, 2010·Brain Pathology·Johannes BergerSonja Forss-Petter
Aug 10, 2019·Human Gene Therapy·Valentina Poletti, Alessandra Biffi
Jun 4, 2018·Brain : a Journal of Neurology·Isabelle WeinhoferJohannes Berger
Nov 27, 2019·Current Treatment Options in Neurology·Eric J MallackFlorian S Eichler
Aug 26, 2018·Nature Reviews. Neurology·Felix NitschkeBerge A Minassian
Jun 26, 2013·Developmental Disabilities Research Reviews·Dietrich MaternSilvia Tortorelli
May 12, 2017·Wiener medizinische Wochenschrift·Bela R TurkAli Fatemi

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Adrenoleukodystrophy

Adrenoleukodystrophy (ALD), the most frequent peroxisomal disorder, is an X-linked disorder caused by a defect in the metabolism of long chain fatty acids leading to demyelination, neurodegeneration, and death. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.